Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tripodo

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Viral Hepatitis|February 10, 2009
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infectionG Tarantino, V D Marco, S Petta, et al.
Current Cancer Drug Targets|June 11, 2009
P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myelomaC Tripodo, A M Florena, P Macor, et al.
Leukemia|October 7, 2014
The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphomaE Ferretti, C Tripodo, G Pagnan, et al.
Oncogene|October 6, 2015
AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progressionN Felli, M C Errico, F Pedini, et al.
Leukemia|May 7, 2011
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironmentE Ferretti, M Bertolotto, S Deaglio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 13, 2014
Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expressionM T Marino, A Grilli, C Baricordi, et al.
Leukemia|June 7, 2014
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in miceP Macor, E Secco, N Mezzaroba, et al.
Nature Communications|September 8, 2023
Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effectsS Cortellino, V Quagliariello, G Delfanti, et al.
Virchows Archiv : an International Journal of Pathology|August 8, 2019
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit : A position paper from the Italian Group of Haematopathology (G.I.E.)Arianna Di Napoli, D Remotti, C Agostinelli, et al.
Virchows Archiv : an International Journal of Pathology|October 31, 2019
Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefitArianna Di Napoli, D Remotti, C Agostinelli, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Viral Hepatitis|February 10, 2009
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infectionG Tarantino, V D Marco, S Petta, et al.
Current Cancer Drug Targets|June 11, 2009
P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myelomaC Tripodo, A M Florena, P Macor, et al.
Leukemia|October 7, 2014
The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphomaE Ferretti, C Tripodo, G Pagnan, et al.
Oncogene|October 6, 2015
AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progressionN Felli, M C Errico, F Pedini, et al.
Leukemia|May 7, 2011
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironmentE Ferretti, M Bertolotto, S Deaglio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 13, 2014
Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expressionM T Marino, A Grilli, C Baricordi, et al.
Leukemia|June 7, 2014
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in miceP Macor, E Secco, N Mezzaroba, et al.
Nature Communications|September 8, 2023
Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effectsS Cortellino, V Quagliariello, G Delfanti, et al.
Virchows Archiv : an International Journal of Pathology|August 8, 2019
A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit : A position paper from the Italian Group of Haematopathology (G.I.E.)Arianna Di Napoli, D Remotti, C Agostinelli, et al.
Virchows Archiv : an International Journal of Pathology|October 31, 2019
Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefitArianna Di Napoli, D Remotti, C Agostinelli, et al.
Pageof 3